Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Rosenke, Kyle ; Feldmann, Heinz ; Westover, Jonna B. ; Hanley, Patrick William ; Martellaro, Cynthia ; ... More +
Rosenke, Kyle ; Feldmann, Heinz ; Westover, Jonna B. ; Hanley, Patrick William ; Martellaro, Cynthia ; Feldmann, Friederike ; Saturday, Greg ; Lovaglio, Jamie ; Scott, Dana P. ; Furuta, Yousuke ; Komeno, Takashi ; Gowen, Brian B. ; Safronetz, David Less -
Description:
Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus-viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.
Subjects:
[+]
Dispatch Use Of Favipiravir To Treat Lassa Virus Infection In Macaques
Source:
Emerg Infect Dis. 24(9):1696-1699.
Pubmed ID:
29882740
Pubmed Central ID:
PMC6106425
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:231a235f42a9857496c04a42a769a855226ef10f925e24ff7da48e62293f0e8c
Download URL:
https://stacks.cdc.gov/view/cdc/58628/cdc_58628_DS1.pdf
File Type:

Supporting Files

• 	18-0233-F1.gif	gif
  	18-0233-F1.jpg	jpeg
  	18-0233-F2.gif	gif
  	18-0233-F2.jpg	jpeg
  	18-0233-Techapp-s1.pdf	pdf
  	18-0233.nxml	xml

More +